Role of Intravitreal Antivascular Endothelial Growth Factor Injections for Choroidal Neovascularization due to Choroidal Osteoma

Table 3

Summary profile comparing patients who underwent PDT plus anti-VEGF to patients who had anti-VEGF therapy alone (excluding chronic cases of CNV) at the 6-month follow-up∗.

Category	Age	Gender (M/F)	Mean follow-up	CNV location	Initial vision (logMar)	Final vision (logMar)	Number of PDT sessions	Number of injections
PDT group 𝑛=6	27	2/4	32 months	Subfoveal 5; Juxtafoveal 1	0.65	0.40	1.8 (1–4)	3.9
No PDT group 𝑛=18	32	7/11	24 months	Subfoveal 8; Juxtafoveal 4; Extrafoveal 4; Peripapillary 2	0.77	0.42	0	4.4

∗VEGF = vascular endothelial growth factor; CNV = choroidal neovascularization; M = male; F = female; PDT = photodynamic therapy; logMar = logarithm of the minimum angle of resolution.